, 2 weeks,
and 6 weeks after
index event

study of transcarotid artery revascularization in patients
with signiÔ¨Åcant carotid artery disease) have been
completed.44-46 The incidence of 30-day stroke in the
symptomatic per protocol patients in both trials was
0.6% in each trial. No deaths occurred in the per protocol
symptomatic patients in ROADSTER-2 for a combined
3